カテゴリー： Market Monitor Global, 世界, 医療/バイオ

冠動脈疾患用薬剤溶出バルーンの世界市場見通し2023年-2029年

◆英語タイトル：Drug Eluting Balloon for Coronary Artery Disease Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY7673 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：71 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Drug Eluting Balloon for Coronary Artery Disease Market 調査レポートは次の情報を含め、グローバルにおけるの冠動脈疾患用薬剤溶出バルーン市場規模と予測を収録しています。・世界の冠動脈疾患用薬剤溶出バルーン市場：売上、2018年-2023年、2024年-2029年
・世界の冠動脈疾患用薬剤溶出バルーン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の冠動脈疾患用薬剤溶出バルーン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「パクリタキセルコーティング」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

冠動脈疾患用薬剤溶出バルーンのグローバル主要企業は、B. Braun、 Yinyi、 Eurocor、 Biotronicなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、冠動脈疾患用薬剤溶出バルーンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の冠動脈疾患用薬剤溶出バルーン市場：タイプ別、2018年-2023年、2024年-2029年
世界の冠動脈疾患用薬剤溶出バルーン市場：タイプ別市場シェア、2022年
・パクリタキセルコーティング、その他コーティング

世界の冠動脈疾患用薬剤溶出バルーン市場：用途別、2018年-2023年、2024年-2029年
世界の冠動脈疾患用薬剤溶出バルーン市場：用途別市場シェア、2022年
・病院、ASC、カテーテル研究室

世界の冠動脈疾患用薬剤溶出バルーン市場：地域・国別、2018年-2023年、2024年-2029年
世界の冠動脈疾患用薬剤溶出バルーン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における冠動脈疾患用薬剤溶出バルーンのグローバル売上、2018年-2023年
・主要企業における冠動脈疾患用薬剤溶出バルーンのグローバル売上シェア、2022年
・主要企業における冠動脈疾患用薬剤溶出バルーンのグローバル販売量、2018年-2023年
・主要企業における冠動脈疾患用薬剤溶出バルーンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
B. Braun、 Yinyi、 Eurocor、 Biotronic

*************************************************************

・調査・分析レポートの概要
冠動脈疾患用薬剤溶出バルーン市場の定義
市場セグメント
世界の冠動脈疾患用薬剤溶出バルーン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の冠動脈疾患用薬剤溶出バルーン市場規模
世界の冠動脈疾患用薬剤溶出バルーン市場規模：2022年 VS 2029年
世界の冠動脈疾患用薬剤溶出バルーン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの冠動脈疾患用薬剤溶出バルーンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の冠動脈疾患用薬剤溶出バルーン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：パクリタキセルコーティング、その他コーティング
冠動脈疾患用薬剤溶出バルーンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、ASC、カテーテル研究室
冠動脈疾患用薬剤溶出バルーンの用途別グローバル売上・予測

・地域別市場分析
地域別冠動脈疾患用薬剤溶出バルーン市場規模 2022年と2029年
地域別冠動脈疾患用薬剤溶出バルーン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
B. Braun、 Yinyi、 Eurocor、 Biotronic
...

The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Balloon for Coronary Artery Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Balloon for Coronary Artery Disease. This report contains market size and forecasts of Drug Eluting Balloon for Coronary Artery Disease in global, including the following market information:
Global Drug Eluting Balloon for Coronary Artery Disease Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Drug Eluting Balloon for Coronary Artery Disease Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Drug Eluting Balloon for Coronary Artery Disease companies in 2022 (%)
The global Drug Eluting Balloon for Coronary Artery Disease market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Paclitaxel Coated Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drug Eluting Balloon for Coronary Artery Disease include B. Braun, Yinyi, Eurocor and Biotronic, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug Eluting Balloon for Coronary Artery Disease manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Eluting Balloon for Coronary Artery Disease Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Drug Eluting Balloon for Coronary Artery Disease Market Segment Percentages, by Type, 2022 (%)
Paclitaxel Coated
Other Coated
Global Drug Eluting Balloon for Coronary Artery Disease Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Drug Eluting Balloon for Coronary Artery Disease Market Segment Percentages, by Application, 2022 (%)
Hospitals
ASCs
Catheterization Laboratory
Global Drug Eluting Balloon for Coronary Artery Disease Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Drug Eluting Balloon for Coronary Artery Disease Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Eluting Balloon for Coronary Artery Disease revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Drug Eluting Balloon for Coronary Artery Disease revenues share in global market, 2022 (%)
Key companies Drug Eluting Balloon for Coronary Artery Disease sales in global market, 2018-2023 (Estimated), (Units)
Key companies Drug Eluting Balloon for Coronary Artery Disease sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
B. Braun
Yinyi
Eurocor
Biotronic
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drug Eluting Balloon for Coronary Artery Disease, market overview.
Chapter 2: Global Drug Eluting Balloon for Coronary Artery Disease market size in revenue and volume.
Chapter 3: Detailed analysis of Drug Eluting Balloon for Coronary Artery Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drug Eluting Balloon for Coronary Artery Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Drug Eluting Balloon for Coronary Artery Disease capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Drug Eluting Balloon for Coronary Artery Disease Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drug Eluting Balloon for Coronary Artery Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drug Eluting Balloon for Coronary Artery Disease Overall Market Size
2.1 Global Drug Eluting Balloon for Coronary Artery Disease Market Size: 2022 VS 2029
2.2 Global Drug Eluting Balloon for Coronary Artery Disease Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Drug Eluting Balloon for Coronary Artery Disease Sales: 2018-2029
3 Company Landscape
3.1 Top Drug Eluting Balloon for Coronary Artery Disease Players in Global Market
3.2 Top Global Drug Eluting Balloon for Coronary Artery Disease Companies Ranked by Revenue
3.3 Global Drug Eluting Balloon for Coronary Artery Disease Revenue by Companies
3.4 Global Drug Eluting Balloon for Coronary Artery Disease Sales by Companies
3.5 Global Drug Eluting Balloon for Coronary Artery Disease Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Drug Eluting Balloon for Coronary Artery Disease Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Drug Eluting Balloon for Coronary Artery Disease Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drug Eluting Balloon for Coronary Artery Disease Players in Global Market
3.8.1 List of Global Tier 1 Drug Eluting Balloon for Coronary Artery Disease Companies
3.8.2 List of Global Tier 2 and Tier 3 Drug Eluting Balloon for Coronary Artery Disease Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Drug Eluting Balloon for Coronary Artery Disease Market Size Markets, 2022 & 2029
4.1.2 Paclitaxel Coated
4.1.3 Other Coated
4.2 By Type – Global Drug Eluting Balloon for Coronary Artery Disease Revenue & Forecasts
4.2.1 By Type – Global Drug Eluting Balloon for Coronary Artery Disease Revenue, 2018-2023
4.2.2 By Type – Global Drug Eluting Balloon for Coronary Artery Disease Revenue, 2024-2029
4.2.3 By Type – Global Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share, 2018-2029
4.3 By Type – Global Drug Eluting Balloon for Coronary Artery Disease Sales & Forecasts
4.3.1 By Type – Global Drug Eluting Balloon for Coronary Artery Disease Sales, 2018-2023
4.3.2 By Type – Global Drug Eluting Balloon for Coronary Artery Disease Sales, 2024-2029
4.3.3 By Type – Global Drug Eluting Balloon for Coronary Artery Disease Sales Market Share, 2018-2029
4.4 By Type – Global Drug Eluting Balloon for Coronary Artery Disease Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Drug Eluting Balloon for Coronary Artery Disease Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 ASCs
5.1.4 Catheterization Laboratory
5.2 By Application – Global Drug Eluting Balloon for Coronary Artery Disease Revenue & Forecasts
5.2.1 By Application – Global Drug Eluting Balloon for Coronary Artery Disease Revenue, 2018-2023
5.2.2 By Application – Global Drug Eluting Balloon for Coronary Artery Disease Revenue, 2024-2029
5.2.3 By Application – Global Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share, 2018-2029
5.3 By Application – Global Drug Eluting Balloon for Coronary Artery Disease Sales & Forecasts
5.3.1 By Application – Global Drug Eluting Balloon for Coronary Artery Disease Sales, 2018-2023
5.3.2 By Application – Global Drug Eluting Balloon for Coronary Artery Disease Sales, 2024-2029
5.3.3 By Application – Global Drug Eluting Balloon for Coronary Artery Disease Sales Market Share, 2018-2029
5.4 By Application – Global Drug Eluting Balloon for Coronary Artery Disease Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Drug Eluting Balloon for Coronary Artery Disease Market Size, 2022 & 2029
6.2 By Region – Global Drug Eluting Balloon for Coronary Artery Disease Revenue & Forecasts
6.2.1 By Region – Global Drug Eluting Balloon for Coronary Artery Disease Revenue, 2018-2023
6.2.2 By Region – Global Drug Eluting Balloon for Coronary Artery Disease Revenue, 2024-2029
6.2.3 By Region – Global Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share, 2018-2029
6.3 By Region – Global Drug Eluting Balloon for Coronary Artery Disease Sales & Forecasts
6.3.1 By Region – Global Drug Eluting Balloon for Coronary Artery Disease Sales, 2018-2023
6.3.2 By Region – Global Drug Eluting Balloon for Coronary Artery Disease Sales, 2024-2029
6.3.3 By Region – Global Drug Eluting Balloon for Coronary Artery Disease Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Drug Eluting Balloon for Coronary Artery Disease Revenue, 2018-2029
6.4.2 By Country – North America Drug Eluting Balloon for Coronary Artery Disease Sales, 2018-2029
6.4.3 US Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.4.4 Canada Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.4.5 Mexico Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Drug Eluting Balloon for Coronary Artery Disease Revenue, 2018-2029
6.5.2 By Country – Europe Drug Eluting Balloon for Coronary Artery Disease Sales, 2018-2029
6.5.3 Germany Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.5.4 France Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.5.5 U.K. Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.5.6 Italy Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.5.7 Russia Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.5.8 Nordic Countries Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.5.9 Benelux Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Drug Eluting Balloon for Coronary Artery Disease Revenue, 2018-2029
6.6.2 By Region – Asia Drug Eluting Balloon for Coronary Artery Disease Sales, 2018-2029
6.6.3 China Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.6.4 Japan Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.6.5 South Korea Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.6.6 Southeast Asia Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.6.7 India Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Drug Eluting Balloon for Coronary Artery Disease Revenue, 2018-2029
6.7.2 By Country – South America Drug Eluting Balloon for Coronary Artery Disease Sales, 2018-2029
6.7.3 Brazil Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.7.4 Argentina Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales, 2018-2029
6.8.3 Turkey Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.8.4 Israel Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.8.5 Saudi Arabia Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
6.8.6 UAE Drug Eluting Balloon for Coronary Artery Disease Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 B. Braun
7.1.1 B. Braun Company Summary
7.1.2 B. Braun Business Overview
7.1.3 B. Braun Drug Eluting Balloon for Coronary Artery Disease Major Product Offerings
7.1.4 B. Braun Drug Eluting Balloon for Coronary Artery Disease Sales and Revenue in Global (2018-2023)
7.1.5 B. Braun Key News & Latest Developments
7.2 Yinyi
7.2.1 Yinyi Company Summary
7.2.2 Yinyi Business Overview
7.2.3 Yinyi Drug Eluting Balloon for Coronary Artery Disease Major Product Offerings
7.2.4 Yinyi Drug Eluting Balloon for Coronary Artery Disease Sales and Revenue in Global (2018-2023)
7.2.5 Yinyi Key News & Latest Developments
7.3 Eurocor
7.3.1 Eurocor Company Summary
7.3.2 Eurocor Business Overview
7.3.3 Eurocor Drug Eluting Balloon for Coronary Artery Disease Major Product Offerings
7.3.4 Eurocor Drug Eluting Balloon for Coronary Artery Disease Sales and Revenue in Global (2018-2023)
7.3.5 Eurocor Key News & Latest Developments
7.4 Biotronic
7.4.1 Biotronic Company Summary
7.4.2 Biotronic Business Overview
7.4.3 Biotronic Drug Eluting Balloon for Coronary Artery Disease Major Product Offerings
7.4.4 Biotronic Drug Eluting Balloon for Coronary Artery Disease Sales and Revenue in Global (2018-2023)
7.4.5 Biotronic Key News & Latest Developments
8 Global Drug Eluting Balloon for Coronary Artery Disease Production Capacity, Analysis
8.1 Global Drug Eluting Balloon for Coronary Artery Disease Production Capacity, 2018-2029
8.2 Drug Eluting Balloon for Coronary Artery Disease Production Capacity of Key Manufacturers in Global Market
8.3 Global Drug Eluting Balloon for Coronary Artery Disease Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Drug Eluting Balloon for Coronary Artery Disease Supply Chain Analysis
10.1 Drug Eluting Balloon for Coronary Artery Disease Industry Value Chain
10.2 Drug Eluting Balloon for Coronary Artery Disease Upstream Market
10.3 Drug Eluting Balloon for Coronary Artery Disease Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Drug Eluting Balloon for Coronary Artery Disease Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Drug Eluting Balloon for Coronary Artery Disease in Global Market
Table 2. Top Drug Eluting Balloon for Coronary Artery Disease Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Drug Eluting Balloon for Coronary Artery Disease Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Drug Eluting Balloon for Coronary Artery Disease Revenue Share by Companies, 2018-2023
Table 5. Global Drug Eluting Balloon for Coronary Artery Disease Sales by Companies, (Units), 2018-2023
Table 6. Global Drug Eluting Balloon for Coronary Artery Disease Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Drug Eluting Balloon for Coronary Artery Disease Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Drug Eluting Balloon for Coronary Artery Disease Product Type
Table 9. List of Global Tier 1 Drug Eluting Balloon for Coronary Artery Disease Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drug Eluting Balloon for Coronary Artery Disease Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Drug Eluting Balloon for Coronary Artery Disease Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Drug Eluting Balloon for Coronary Artery Disease Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Drug Eluting Balloon for Coronary Artery Disease Sales (Units), 2018-2023
Table 15. By Type - Global Drug Eluting Balloon for Coronary Artery Disease Sales (Units), 2024-2029
Table 16. By Application – Global Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Drug Eluting Balloon for Coronary Artery Disease Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Drug Eluting Balloon for Coronary Artery Disease Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Drug Eluting Balloon for Coronary Artery Disease Sales (Units), 2018-2023
Table 20. By Application - Global Drug Eluting Balloon for Coronary Artery Disease Sales (Units), 2024-2029
Table 21. By Region – Global Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Drug Eluting Balloon for Coronary Artery Disease Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Drug Eluting Balloon for Coronary Artery Disease Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Drug Eluting Balloon for Coronary Artery Disease Sales (Units), 2018-2023
Table 25. By Region - Global Drug Eluting Balloon for Coronary Artery Disease Sales (Units), 2024-2029
Table 26. By Country - North America Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Drug Eluting Balloon for Coronary Artery Disease Sales, (Units), 2018-2023
Table 29. By Country - North America Drug Eluting Balloon for Coronary Artery Disease Sales, (Units), 2024-2029
Table 30. By Country - Europe Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Drug Eluting Balloon for Coronary Artery Disease Sales, (Units), 2018-2023
Table 33. By Country - Europe Drug Eluting Balloon for Coronary Artery Disease Sales, (Units), 2024-2029
Table 34. By Region - Asia Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Drug Eluting Balloon for Coronary Artery Disease Sales, (Units), 2018-2023
Table 37. By Region - Asia Drug Eluting Balloon for Coronary Artery Disease Sales, (Units), 2024-2029
Table 38. By Country - South America Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Drug Eluting Balloon for Coronary Artery Disease Sales, (Units), 2018-2023
Table 41. By Country - South America Drug Eluting Balloon for Coronary Artery Disease Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales, (Units), 2024-2029
Table 46. B. Braun Company Summary
Table 47. B. Braun Drug Eluting Balloon for Coronary Artery Disease Product Offerings
Table 48. B. Braun Drug Eluting Balloon for Coronary Artery Disease Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. B. Braun Key News & Latest Developments
Table 50. Yinyi Company Summary
Table 51. Yinyi Drug Eluting Balloon for Coronary Artery Disease Product Offerings
Table 52. Yinyi Drug Eluting Balloon for Coronary Artery Disease Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Yinyi Key News & Latest Developments
Table 54. Eurocor Company Summary
Table 55. Eurocor Drug Eluting Balloon for Coronary Artery Disease Product Offerings
Table 56. Eurocor Drug Eluting Balloon for Coronary Artery Disease Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Eurocor Key News & Latest Developments
Table 58. Biotronic Company Summary
Table 59. Biotronic Drug Eluting Balloon for Coronary Artery Disease Product Offerings
Table 60. Biotronic Drug Eluting Balloon for Coronary Artery Disease Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Biotronic Key News & Latest Developments
Table 62. Drug Eluting Balloon for Coronary Artery Disease Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 63. Global Drug Eluting Balloon for Coronary Artery Disease Capacity Market Share of Key Manufacturers, 2021-2023
Table 64. Global Drug Eluting Balloon for Coronary Artery Disease Production by Region, 2018-2023 (Units)
Table 65. Global Drug Eluting Balloon for Coronary Artery Disease Production by Region, 2024-2029 (Units)
Table 66. Drug Eluting Balloon for Coronary Artery Disease Market Opportunities & Trends in Global Market
Table 67. Drug Eluting Balloon for Coronary Artery Disease Market Drivers in Global Market
Table 68. Drug Eluting Balloon for Coronary Artery Disease Market Restraints in Global Market
Table 69. Drug Eluting Balloon for Coronary Artery Disease Raw Materials
Table 70. Drug Eluting Balloon for Coronary Artery Disease Raw Materials Suppliers in Global Market
Table 71. Typical Drug Eluting Balloon for Coronary Artery Disease Downstream
Table 72. Drug Eluting Balloon for Coronary Artery Disease Downstream Clients in Global Market
Table 73. Drug Eluting Balloon for Coronary Artery Disease Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Drug Eluting Balloon for Coronary Artery Disease Segment by Type in 2022
Figure 2. Drug Eluting Balloon for Coronary Artery Disease Segment by Application in 2022
Figure 3. Global Drug Eluting Balloon for Coronary Artery Disease Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drug Eluting Balloon for Coronary Artery Disease Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Drug Eluting Balloon for Coronary Artery Disease Revenue, 2018-2029 (US$, Mn)
Figure 7. Drug Eluting Balloon for Coronary Artery Disease Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Drug Eluting Balloon for Coronary Artery Disease Revenue in 2022
Figure 9. By Type - Global Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share, 2018-2029
Figure 11. By Type - Global Drug Eluting Balloon for Coronary Artery Disease Sales Market Share, 2018-2029
Figure 12. By Type - Global Drug Eluting Balloon for Coronary Artery Disease Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share, 2018-2029
Figure 15. By Application - Global Drug Eluting Balloon for Coronary Artery Disease Sales Market Share, 2018-2029
Figure 16. By Application - Global Drug Eluting Balloon for Coronary Artery Disease Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share, 2018-2029
Figure 20. By Region - Global Drug Eluting Balloon for Coronary Artery Disease Sales Market Share, 2018-2029
Figure 21. By Country - North America Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share, 2018-2029
Figure 22. By Country - North America Drug Eluting Balloon for Coronary Artery Disease Sales Market Share, 2018-2029
Figure 23. US Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Drug Eluting Balloon for Coronary Artery Disease Sales Market Share, 2018-2029
Figure 28. Germany Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 29. France Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Drug Eluting Balloon for Coronary Artery Disease Sales Market Share, 2018-2029
Figure 37. China Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 41. India Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share, 2018-2029
Figure 43. By Country - South America Drug Eluting Balloon for Coronary Artery Disease Sales Market Share, 2018-2029
Figure 44. Brazil Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales Market Share, 2018-2029
Figure 48. Turkey Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$, Mn), 2018-2029
Figure 52. Global Drug Eluting Balloon for Coronary Artery Disease Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Drug Eluting Balloon for Coronary Artery Disease by Region, 2022 VS 2029
Figure 54. Drug Eluting Balloon for Coronary Artery Disease Industry Value Chain
Figure 55. Marketing Channels

※参考情報

冠動脈疾患用薬剤溶出バルーンは、現在の心血管治療における重要な進展の一つです。この技術は、冠動脈における狭窄や閉塞の治療に用いられ、薬剤を含んだバルーンを使って血管を拡張し、その後に薬剤を局所的に放出することによって、再狭窄のリスクを低減します。以下では、冠動脈疾患用薬剤溶出バルーンの定義、特徴、種類、用途、関連技術について詳しく説明します。

まず、冠動脈疾患用薬剤溶出バルーンの定義ですが、これは冠動脈に狭窄や閉塞を伴う病変に対して使用される医療機器です。通常のバルーンカテーテルと異なり、薬剤がバルーンの表面に塗布されており、バルーンが拡張される際に薬剤が血管内に放出され、内径の拡張が行われます。この薬剤により、細胞増殖が抑制され、再狭窄のリスクが著しく低下します。

次に、特徴について掘り下げます。薬剤溶出バルーンの最大の特徴は、局所治療が可能であるという点です。薬剤を直接病変部位に投与するため、全身への影響を最小限に抑えることができます。また、バルーンの拡張によって物理的に狭窄部位を開くと同時に、放出される薬剤によって、再狭窄の原因となる内膜の過剰な細胞増殖を抑える効果があります。これにより、治療後の血管の安定性が向上し、患者の長期的な予後が改善されることが期待されます。

薬剤溶出バルーンにはいくつかの種類があります。一般的に用いられる薬剤には、シロリムスやパクリタキセルといった抗増殖剤が含まれています。これらは細胞周期の特定の段階で細胞増殖を抑制し、内膜の再生を遅らせる効果があります。それぞれの薬剤には異なるメカニズムと特徴があり、適応症や患者の状態に応じて使い分けられます。

薬剤溶出バルーンの用途としては、特に狭心症や心筋梗塞後の治療に有用です。以前は、バルーン治療やステント埋置が行われていましたが、再狭窄のリスクが常に伴いました。薬剤溶出バルーンは、これに対する効果的な解決策の一つとして、広く使用されるようになりました。特に、卒倒やアテローム性動脈硬化が進行している場合において、従来の治療法に比べて優れた成果が得られることが多いです。

関連技術についても触れておきます。薬剤溶出バルーンの発展には、いくつかの関連技術が来ています。その一つが、バイオデグレーダブルポリマー技術です。この技術を使うことで、バルーンの材料自体が体内で時間とともに分解され、長期間の薬剤放出が可能になっています。また、イメージング技術の進化により、治療時にリアルタイムで血管の状態を確認できるため、より精密な治療が実現されています。

さらに、薬剤溶出バルーンは、単に冠動脈疾患のみならず、末梢動脈疾患や他の血管における治療にも応用が広がっています。これにより、弁膜症や重度の動脈硬化を抱える患者に対しても、新たな治療選択肢を提供することが可能です。

最後に、薬剤溶出バルーンの使用にあたっては、患者の状態や病歴、リスク因子を十分に評価することが重要です。技術の進歩がもたらす利点を最大限に活かしつつ、適切な治療戦略を立てることが求められます。

結論として、冠動脈疾患用薬剤溶出バルーンは、心血管疾患の治療において画期的な道具であり、これまでの治療法に比べて再狭窄のリスクを大幅に低下させることが可能です。今後も技術革新が続く中で、患者に対するより効果的な治療が期待されます。健康な心血管系を維持するために、医療現場ではこれらの技術を適切に活用し、患者一人ひとりに最適な治療を提供していくことが重要です。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 冠動脈疾患用薬剤溶出バルーンの世界市場見通し2023年-2029年(Drug Eluting Balloon for Coronary Artery Disease Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

冠動脈疾患用薬剤溶出バルーンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp